Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 14/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32678640 | 1.00 | EPHX1 (0.44) | EPHX1ACHEALDH1A1ATMHPGD | |
| SCHEMBL32678639 | 1.00 | EPHX1 (0.44) | EPHX1ACHEALDH1A1ATMHPGD | |
| SCHEMBL21250185 | 0.87 | EPHX1 (0.42) | EPHX1ACHEALDH1A1ATMRAB9A | |
| SCHEMBL30849242 | 0.84 | EPHX1 (0.40) | EPHX1ACHEALDH1A1ATMRAB9A | |
| SCHEMBL29739429 | 0.78 | EPHX1 (0.43) | EPHX1ACHEALDH1A1ATMRAB9A | |
| SCHEMBL7963422 | 0.78 | EPHX1 (0.43) | EPHX1ACHEALDH1A1ATMRAB9A | |
| SCHEMBL30849239 | 0.77 | EPHX1 (0.35) | EPHX1ACHEALDH1A1ATM | |
| SCHEMBL30292346 | 0.77 | EPHX1 (0.42) | EPHX1ACHEALDH1A1ATMRAB9A | |
| SCHEMBL533667 | 0.77 | EPHX2 (0.62) | — | |
| SCHEMBL2722735 | 0.76 | EPHX1 (0.44) | EPHX1ACHEALDH1A1ATMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026042018-A1 | 4-{4-[(1-{[4-(PROPAN-2-YL)PHENYL]CARBAMOYL)-D-PROLYL)AMINO]CYCLOHEXYL}BENZOIC ACID DERIVATIVES AS GIPR ANTAGONISTS FOR THE TREATMENT OF DIABETES | PFIZER INC. (US) | 2026-02-26 | — | — | WO | disclosed |